A scoping review on patient heterogeneity in economic evaluations of precision medicine based on basket trials.
Marzieh NosratiShekoufeh NikfarMandana HasanzadPublished in: Expert review of pharmacoeconomics & outcomes research (2022)
Type of disease is not considered a contributing factor in population heterogeneity, and the probable appropriate method for this issue could be individual-based models.
Keyphrases